Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Population Studies
|
February 19, 2008
Counting women's labour: a reanalysis of children's net production using Cain's data from a Bangladeshi village
Rachel Sullivan Robinson, Ronald D Lee, Karen L Kramer
Journal of Economic Behavior & Organization
|
January 11, 2011
The Evolutionary Theory of Time Preferences and Intergenerational Transfers
C Y Cyrus Chu, Hung-Ken Chien, Ronald D Lee
Theoretical Population Biology
|
January 8, 2008
Explaining the optimality of U-shaped age-specific mortality
C Y Cyrus Chu, Hung-Ken Chien, Ronald D Lee
Clinical Drug Investigation
|
December 11, 2008
Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies
Majid Vakily, Ronald D Lee, Jingtao Wu, et al.
Population and Development Review
|
July 16, 2011
Fiscal externalities of becoming a parent
Douglas A Wolf, Ronald D Lee, Timothy Miller, et al.
Journal of the American College of Cardiology
|
April 3, 2012
A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers
Andrew L Frelinger, Ronald D Lee, Darcy J Mulford, et al.
Journal of the American College of Cardiology
|
January 22, 2013
Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in platelet function
Andrew L Frelinger, Deepak L Bhatt, Ronald D Lee, et al.
Pharmaceutical Research
|
October 23, 2004
Metabolism and disposition of the HIV-1 protease inhibitor lopinavir (ABT-378) given in combination with ritonavir in rats, dogs, and humans
Gondi N Kumar, Venkata K Jayanti, Marianne K Johnson, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Population Studies
|
February 19, 2008
Counting women's labour: a reanalysis of children's net production using Cain's data from a Bangladeshi village
Rachel Sullivan Robinson, Ronald D Lee, Karen L Kramer
Journal of Economic Behavior & Organization
|
January 11, 2011
The Evolutionary Theory of Time Preferences and Intergenerational Transfers
C Y Cyrus Chu, Hung-Ken Chien, Ronald D Lee
Theoretical Population Biology
|
January 8, 2008
Explaining the optimality of U-shaped age-specific mortality
C Y Cyrus Chu, Hung-Ken Chien, Ronald D Lee
Clinical Drug Investigation
|
December 11, 2008
Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies
Majid Vakily, Ronald D Lee, Jingtao Wu, et al.
Population and Development Review
|
July 16, 2011
Fiscal externalities of becoming a parent
Douglas A Wolf, Ronald D Lee, Timothy Miller, et al.
Journal of the American College of Cardiology
|
April 3, 2012
A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers
Andrew L Frelinger, Ronald D Lee, Darcy J Mulford, et al.
Journal of the American College of Cardiology
|
January 22, 2013
Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in platelet function
Andrew L Frelinger, Deepak L Bhatt, Ronald D Lee, et al.
Pharmaceutical Research
|
October 23, 2004
Metabolism and disposition of the HIV-1 protease inhibitor lopinavir (ABT-378) given in combination with ritonavir in rats, dogs, and humans
Gondi N Kumar, Venkata K Jayanti, Marianne K Johnson, et al.
Page
of 2